Published in

Elsevier, Atherosclerosis, (256), p. 1-6, 2017

DOI: 10.1016/j.atherosclerosis.2016.11.019

Links

Tools

Export citation

Search in Google Scholar

Inhibitory effect of PCSK9 on Abca1 protein expression and cholesterol efflux in macrophages

Journal article published in 2016 by Maria Pia Adorni, Eleonora Cipollari, Elda Favari, Ilaria Zanotti ORCID, Francesca Zimetti, Alberto Corsini ORCID, Chiara Ricci, Franco Bernini, Nicola Ferr, Nicola Ferri ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Proprotein convertase subtilisin/kexin type 9 (PCSK9) may have extra-hepatic effects on cholesterol homeostasis of vascular macrophages. In this study, we aimed to investigate PCSK9 role on the anti-atherogenic process of ATP binding cassette transporter A1 (Abca1)-mediated cholesterol efflux.